神経リハビリテーション装置の市場規模、シェア、動向分析レポート：製品別、治療領域別、地域別、セグメント予測、2024年～2030年

神経リハビリテーション装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の神経リハビリテーション装置市場規模は、2024年から2030年にかけて13.9%のCAGRを記録し、2030年には49億8,000万米ドルに達すると予測されています。

新規製品発売のための研究開発重視の高まり、患者の転帰を向上させる革新的技術＆デバイスの生産、ブレイン・コンピュータ・インターフェイス（BCI）や神経刺激デバイスを含む神経補綴デバイスの製造などの医療技術の進歩、遠隔医療＆遠隔リハビリテーション・ソリューションの採用増加などが、業界成長の原動力となっています。患者の転帰を改善する最先端のツールや技術の開拓も市場成長の原動力となっています。ヘルスケアコストが上昇すると、最先端の神経リハビリ機器を購入するための財源が増えます。

莫大なヘルスケア予算を持つ企業によって、ニューロリハビリテーション分野の研究開発に資金が確保されるかもしれないです。その結果、神経リハビリテーションのための斬新で改良されたツールが開発されるかもしれないです。例えば、2023年3月、インテリジェントなリハビリテーション・ソリューションを提供する中国企業SiYi Intelligenceは、Tao CapitalとChengdu Bio-town Equity Investment Fundの参加を得て、シリーズA投資ラウンドで150億米ドルを調達したことを最近明らかにしました。同企業はこの資金で、神経リハビリ・ソリューション統合の研究開発を進め、新たなデジタル・リハビリ・サービス・プラットフォームを構築するつもりだっています。医療機器メーカー、学術機関、ヘルスケアプロバイダーなどの主要な業界関係者は、製品開発のための戦略的協力やパートナーシップに関与しています。

研究開発資源は、共同作業を通じて組み合わせることができ、より迅速な発明と、より効率的な製品の開発を促進します。バーチャルリアリティ（VR）やARのような技術は、神経リハビリテーションに利用されています。VRやARのような技術は、運動能力や認知能力の回復をサポートする刺激的な活動に患者が参加できるような、魅力的な治療環境をデザインすることができます。セラピストはVRやARを通じてリアルタイムのフィードバックを受けることができます。例えば、2023年4月には、VHA（退役軍人健康管理局）のヘルスケア・イノベーション・アンド・ラーニング局と、最先端治療を専門とする世界のヘルスケア企業であるPenumbra, Inc.が、VRベースのリハビリテーション・ヘルスケア・ソリューションのテスト、共同開発、導入に向けて協力することを発表しました。

神経リハビリテーション装置市場レポートハイライト

• 2023年には、ロボット工学と神経技術の継続的な進歩により、より洗練された効果的な神経ロボットデバイスが開発され、神経ロボット分野が36.0%のシェアで市場を独占しました。
• 脳卒中治療領域セグメントは、2023年に44.3%の最大の収益シェアを占めました。在宅での神経リハビリ技術の利用が普及しています。
• 脳卒中患者が自宅の便利な場所で回復を続けられるよう、遠隔モニタリングや遠隔リハビリテーション・プログラムを通じてリハビリテーション・サービスの利用可能性が高まっています。
• 2023年の世界市場は北米が39.08%のシェアを占めました。この地域市場は、新興企業だけでなく少数の既存企業も存在するため競合が激しいです。
• これらの企業は、製品の革新、合併、買収、提携を通じて、より高い業界シェアを獲得しようと努力しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 神経リハビリテーション装置市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 神経リハビリテーション装置市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 神経リハビリテーション装置市場：製品の推定・動向分析

• 定義と範囲
• 製品市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品別の世界の神経リハビリテーション装置市場の見通し
• 以下の市場規模、予測および動向分析、2018年から2030年まで

第5章 神経リハビリテーション装置市場：治療領域の推定・動向分析

• 定義と範囲
• 治療領域の市場シェア、2023年と2030年
• セグメントダッシュボード
• 治療領域別の神経リハビリテーション装置市場の見通し
• 以下の市場規模、予測および動向分析、2018年から2030年まで

第6章 神経リハビリテーション装置市場：地域の推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2023年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場アプリケーション、予測および動向分析、2018年から2030年：
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • Bioventus
  • Ectron
  • Hocoma
  • Medtronic
  • Tyromotion Inc.
  • Abbott
  • Biometrics Ltd
  • Bionik Laboratories Corp.（BNKL）
  • BioXtreme Ltd.
  • Ekso Bionics
  • Saebo, Inc
  • Kinova inc.
  • Kinestica

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global neurorehabilitation devices market, by region 2018 - 2030 (USD Million)
• Table 4. Global neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 5. Global neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 6. North America neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
• Table 7. North America neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 8. North America neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 9. U.S. neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 10. U.S. neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 11. Canada neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 12. Canada neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 13. Europe neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
• Table 14. Europe neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 15. Europe neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 16. UK neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 17. UK neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 18. Germany neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 19. Germany neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 20. France neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 21. France neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 22. Italy neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 23. Italy neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 24. Spain neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 25. Spain neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 26. Denmark neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 27. Denmark neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 28. Sweden neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 29. Sweden neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 30. Norway neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 31. Norway neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 32. Asia Pacific neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
• Table 33. Asia Pacific neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 34. Asia Pacific neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 35. Japan neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 36. Japan neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 37. China neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 38. China neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 39. India neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 40. India neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 41. Australia neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 42. Australia neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 43. Thailand neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 44. Thailand neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 45. South Korea neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 46. South Korea neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 47. Latin America neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
• Table 48. Latin America neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 49. Latin America neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 50. Brazil neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 51. Brazil neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 52. Mexico neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 53. Mexico neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 54. Argentina neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 55. Argentina neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 56. MEA neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
• Table 57. MEA neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 58. MEA neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 59. South Africa neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 60. South Africa neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 61. Saudi Arabia neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 62. Saudi Arabia neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 63. UAE neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 64. UAE neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
• Table 65. Kuwait neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
• Table 66. Kuwait neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Neurorehabilitation devices market: Market snapshot
• Fig. 9 Neurorehabilitation devices market: Market segmentation
• Fig. 10 Neurorehabilitation devices market Strategy framework
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Neurorehabilitation devices market driver impact
• Fig. 14 Neurorehabilitation devices market restraint impact
• Fig. 15 Neurorehabilitation devices market porter's five forces analysis
• Fig. 16 Neurorehabilitation devices market PESTEL analysis
• Fig. 17 Neurorehabilitation devices market segment dashboard
• Fig. 18 Neurorehabilitation devices market: Product movement Analysis
• Fig. 19 Neurorobotics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Brain-computer interface market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Wearable devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Non-invasive stimulators market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Neurorehabilitation devices market: Therapy area movement Analysis
• Fig. 25 Stroke market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Parkinson's disease market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Multiple sclerosis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Cerebral palsy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Global Neurorehabilitation devices market: Regional movement analysis
• Fig. 31 Global Neurorehabilitation devices market: Regional outlook and key takeaways
• Fig. 32 Global market share, by region
• Fig. 33 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Neurorehabilitation Devices Market Growth & Trends:

The global neurorehabilitation devices market size is anticipated to reach USD 4.98 billion by 2030, registering a CAGR of 13.9% from 2024 to 2030, according to a new report by Grand View Research, Inc.. Increasing emphasis on R&D for novel product launches, production of innovative technology & devices to enhance patient outcomes, advancements in medical technology, such as manufacturing of neuroprosthetic devices, including brain-computer interfaces (BCIs) and neurostimulation devices, and the increasing adoption of telemedicine & remote rehabilitation solutions drive the industry growth. The development of cutting-edge tools and technologies to improve patient outcomes also drives market growth. Greater financial resources are available to purchase cutting-edge neurorehabilitation equipment when healthcare costs rise.

Funds might be set aside for R&D in the neurorehabilitation sector by business players with sizable healthcare budgets. The development of novel and improved tools for neurological rehabilitation may result from this. For instance, in March 2023, SiYi Intelligence, a Chinese company that offers intelligent rehabilitation solutions, recently revealed that it had raised USD 15 billion in a Series A investment round, with participation from Tao Capital and Chengdu Bio-town Equity Investment Fund. The business intended to use the funds to advance the R&D of neurorehabilitation solution integration and create a new digital rehabilitation service platform. Major industry participants, such as manufacturers of medical devices, academic institutions, and healthcare providers are involved in the strategic collaborations and partnerships for product development.

R&D resources can be combined through collaborative efforts, promoting quicker inventions and the development of more efficient products. The technologies like virtual reality (VR) and AR are being used in neurorehabilitation. They can design therapeutic settings that are engaging, allowing patients to take part in stimulating activities that support the restoration of motor and cognitive abilities. Therapists can receive real-time feedback through VR and AR. For instance, in April 2023, the Office of Healthcare Innovation and Learning of the VHA (Veterans Health Administration) and Penumbra, Inc., a global healthcare company specializing in cutting-edge therapies, announced their collaboration to work together to test, co-develop, and implement VR-based rehabilitative healthcare solutions.

Neurorehabilitation Devices Market Report Highlights:

• In 2023, the neurorobotics segment dominated the market with a share of 36.0% due to the ongoing advancements in robotics and neurotechnology, which led to the development of more sophisticated and effective neurorobotic devices
• The stroke therapy area segment held the largest revenue share of 44.3% in 2023. The use of home-based neurorehabilitation techniques is becoming more popular
• The availability of rehabilitation services is increased via remote monitoring and telerehabilitation programs that enable stroke patients to continue their recovery in the convenience of their homes
• North America dominated the global market with a share of 39.08% in 2023. The regional market is competitive due to the presence of a few established as well as emerging players
• These companies strive to capture higher industry shares through product innovations, mergers, acquisitions, and partnerships

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Therapy area
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Therapy area outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Increasing incidence of neurological diseases
    • 3.4.1.2. Technological advancements
    • 3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. High cost of devices
    • 3.4.2.2. Complex regulatory framework
• 3.5. Neurorehabilitation Devices Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Neurorobotics
  • 4.1.2. Brain-Computer Interface
  • 4.1.3. Wearable Devices
  • 4.1.4. Non-Invasive Stimulators
  • 4.1.5. Others
• 4.2. Product Market Share, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Neurorehabilitation Devices Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Neurorobotics
    • 4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Brain-Computer Interface
    • 4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Wearable Devices
    • 4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Non-Invasive Stimulators
    • 4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurorehabilitation Devices Market: Therapy Area Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Stroke
  • 5.1.2. Parkinson's Disease
  • 5.1.3. Multiple Sclerosis
  • 5.1.4. Cerebral Palsy
  • 5.1.5. Others
• 5.2. Therapy area Market Share, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Neurorehabilitation Devices Market by Therapy Area Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Stroke
    • 5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Parkinson's Disease
    • 5.5.2.1. Parkinson's disease market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Multiple Sclerosis
    • 5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Cerebral Palsy
    • 5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Others
    • 5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurorehabilitation Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional market share analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Regional Market Share and Leading Players, 2023
  • 6.4.1. North America
  • 6.4.2. Europe
  • 6.4.3. Asia Pacific
  • 6.4.4. Latin America
  • 6.4.5. Middle East and Africa
• 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 6.6. North America
  • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.6.2. U.S.
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 6.6.3. Canada
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 6.7. Europe
  • 6.7.1. UK
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive Scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement scenario
    • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
  • 6.7.2. Germany
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 6.7.3. France
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
  • 6.7.4. Italy
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 6.7.5. Spain
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 6.7.6. Denmark
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 6.7.7. Sweden
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 6.7.8. Norway
    • 6.7.8.1. Key country dynamics
    • 6.7.8.2. Competitive Scenario
    • 6.7.8.3. Regulatory framework
    • 6.7.8.4. Reimbursement scenario
    • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
• 6.8. Asia Pacific
  • 6.8.1. Japan
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Competitive Scenario
    • 6.8.1.3. Regulatory framework
    • 6.8.1.4. Reimbursement scenario
    • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 6.8.2. India
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 6.8.3. China
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 6.8.4. South Korea
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 6.8.5. Australia
    • 6.8.5.1. Key country dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 6.8.6. Thailand
    • 6.8.6.1. Key country dynamics
    • 6.8.6.2. Competitive Scenario
    • 6.8.6.3. Regulatory framework
    • 6.8.6.4. Reimbursement scenario
    • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 6.9. Latin America
  • 6.9.1. Brazil
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Competitive Scenario
    • 6.9.1.3. Regulatory framework
    • 6.9.1.4. Reimbursement scenario
    • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 6.9.2. Mexico
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 6.9.3. Argentina
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 6.10. MEA
  • 6.10.1. South Africa
    • 6.10.1.1. Key country dynamics
    • 6.10.1.2. Competitive Scenario
    • 6.10.1.3. Regulatory framework
    • 6.10.1.4. Reimbursement scenario
    • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 6.10.2. Saudi Arabia
    • 6.10.2.1. Key country dynamics
    • 6.10.2.2. Competitive Scenario
    • 6.10.2.3. Regulatory framework
    • 6.10.2.4. Reimbursement scenario
    • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 6.10.3. UAE
    • 6.10.3.1. Key country dynamics
    • 6.10.3.2. Competitive Scenario
    • 6.10.3.3. Regulatory framework
    • 6.10.3.4. Reimbursement scenario
    • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 6.10.4. Kuwait
    • 6.10.4.1. Key country dynamics
    • 6.10.4.2. Competitive Scenario
    • 6.10.4.3. Regulatory framework
    • 6.10.4.4. Reimbursement scenario
    • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Bioventus
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Ectron
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Hocoma
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Medtronic
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Tyromotion Inc.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Abbott
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Biometrics Ltd
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Bionik Laboratories Corp. (BNKL)
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. BioXtreme Ltd.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Ekso Bionics
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. Saebo, Inc
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. Kinova inc.
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives
  • 7.3.16. Kinestica
    • 7.3.16.1. Company overview
    • 7.3.16.2. Financial performance
    • 7.3.16.3. Product benchmarking
    • 7.3.16.4. Strategic initiatives